Cubist Systematic Strategies’s PhenomeX Inc. Common Stock CELL Stock Holding History

Cubist Systematic Strategies’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15,172	Closed	-$7.43K	–	4174
2023 Q2	$7.43K	Buy	+15,172	New	+$12.4K	﹤0.01%	3280
2023 Q1	–	Sell	-66,031	Closed	-$177K	–	4648
2022 Q4	$177K	Buy	+66,031	New	+$174K	﹤0.01%	3638
2022 Q3	–	Sell	-21,864	Closed	-$109K	–	4898
2022 Q2	$109K	Sell	21,864 -239,421	-92%	-$1.25M	﹤0.01%	3950
2022 Q1	$1.86M	Buy	261,285 +140,810	+117%	+$1.16M	0.02%	1543
2021 Q4	$2.19M	Sell	120,475 -39,958	-25%	-$862K	0.02%	1285
2021 Q3	$3.14M	Buy	160,433 +72,952	+83%	+$2.77M	0.04%	731
2021 Q2	$3.92M	Sell	87,481 -123,229	-58%	-$5.71M	0.04%	683
2021 Q1	$10.6M	Buy	+210,710	New	+$14.4M	0.14%	146
2020 Q4	–	Sell	-4,246	Closed	-$324K	–	2758
2020 Q3	$324K	Buy	+4,246	New	+$270K	﹤0.01%	1961

Other funds holding CELL

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

TAM

Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cubist Systematic Strategies's CELL Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 15,172 shares — an estimated $7.43K sold.

Cubist Systematic Strategies first reported a position in CELL in Q3 2020 and held it in 9 quarters. The position peaked at $10.6M in Q1 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

Cubist Systematic Strategies reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 15,172 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $7.43K.
Cubist Systematic Strategies first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 9 quarters.
Cubist Systematic Strategies's PhenomeX Inc. Common Stock position peaked at $10.6M in Q1 2021.
57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.